Clinical Trial Update: Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating the safety and immune response of a DNA HIV vaccine (VRC-HIVDNA009-00-VP) in individuals with acute HIV infection completed Phase 1/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VRC-HIVDNA009-00-VP (HIV DNA vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED